p.DOM-WT1-126 DNA vaccine / Inovio  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
p.DOM-WT1-126 DNA vaccine / Inovio
NCT01334060 / 2009-017340-14: WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation

Completed
2
23
Europe
p.DOM-WT1-37 DNA Vaccine and p.DOM-WT1-126 DNA Vaccine
University Hospital Southampton NHS Foundation Trust, Imperial College Healthcare NHS Trust, Royal Devon and Exeter NHS Foundation Trust, Inovio Pharmaceuticals, Efficacy and Mechanism Evaluation (EME) Programme, Leukemia Research Fund
Leukaemia (Acute), Leukaemia (Chronic), Leukaemia (Acute Myeloid), Leukaemia (Acute Lymphoblastic), Leukaemia (Acute Promyelocytic)
02/13
02/13

Download Options